Actriib fusion polypeptides and uses therefor
CA 2501180 A1 · Owner: Wyeth · Inventors: Wolfman, Neil M.; Bouxsein, Mary L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods and compositions for inhibiting growth and differentiation factor-8 (GDF-8) activity in vitro and in vivo are provided.The methods and composition can be used for diagnosing, preventing or treating degenerative disorders of muscle, bone, or glucose homeostasis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 24, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 24, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 24, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.